We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Smoke Toxic Byproducts Could Harm Surgeons

By HospiMedica International staff writers
Posted on 17 Jun 2010
Surgical smoke, a common byproduct of procedures such as combined transurethral resection and vaporization of the prostate (CTURVP), contains toxic chemicals, including some explosive and harmful carcinogens, according to a new study.

Researchers from Chonbuk National University (Jeonbuk, Korea) and Wonkwang University (Iksan City, Korea) analyzed smoke samples from six CTURVP procedures. More...
A total of 12 smoke samples were collected from a continuous irrigation suction drainage system during surgery. The gases were quantitatively and qualitatively analyzed by a gas chromatography-mass spectrometry (GC-MS) system equipped with a purge and trap sample injector.

The researchers found that the main chemical constituents of surgical smokes produced in CTURVP are propylene, allene, isobutylene, 1,3-butadiene, vinylacetylene, mecaptomethane, ethylacetylene, diacetylene, 1-pentene, EtOH, piperylene, propenylacetylene,1,4-pentadiene, cyclopentadiene, acrylnitrile and butyrolacton. All of the chemical are considered toxic, and three of them are carcinogenic. Several of the chemicals can cause central nervous system depression and skin, eye, and respiratory irritation. The study was presented as a poster session at the European Association of Urology (EAU) annual meeting, held during April 2010 in Barcelona (Spain).

"Higher quality filter masks, smoke evacuation device, and/or smoke filter should be developed for safety for operating personnel and patients in CTURVP,” concluded lead author Yun Jo Chung, Ph. D., and colleagues.

"This is certainly an occupational hazard that urologists and operating room personnel working with urologists may be exposed to more often than they would like. Ascertaining the degree to which this exposure may contribute to any ill effects in those people who are exposed will require further study,” commented Anthony Smith, M.D., a spokesperson for the American urological Association (AUA).

Related Links:

Chonbuk National University
Wonkwang University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.